Approval · Notice of Compliance 7852 · 2006
AVALIDE: Notice of Compliance 7852
Issued March 29, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7852
- Date
- March 29, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin ii at1 receptor blocker / diuretic
Products in this notice
Medicinal ingredients
- IRBESARTAN 150 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- IRBESARTAN 300 MG per TAB